(Q40694357)

22 September 2017

1 reference

title

Topoisomerase expression in cancer cell lines and clinical samples (English)

1 reference

22 September 2017

Doyle LA

1

1 reference

22 September 2017

language of work or name

1 reference

1 January 1994

1 reference

Cancer Chemotherapy and Pharmacology

22 September 2017

published in

1 reference

22 September 2017

volume

34 Suppl

1 reference

22 September 2017

page(s)

S32-40

1 reference

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia

22 September 2017

cites work

1 reference

12 December 2020

Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.

1 reference

12 December 2020

Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer

1 reference

12 December 2020

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction

1 reference

12 December 2020

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial

1 reference

12 December 2020

Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines

1 reference

12 December 2020

Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.

1 reference

12 December 2020

Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression

1 reference

12 December 2020

Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines

1 reference

12 December 2020

Altered function of DNA topoisomerases as a basis for antineoplastic drug action

1 reference

12 December 2020

Etoposide-induced DNA cleavage in human leukemia cells

1 reference

12 December 2020

Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II

1 reference

12 December 2020

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation

1 reference

12 December 2020

Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells

1 reference

12 December 2020

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy

1 reference

12 December 2020

Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell Lines

1 reference

12 December 2020

Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells

1 reference

12 December 2020

DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors

1 reference

12 December 2020

Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.

1 reference

12 December 2020

Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II

1 reference

12 December 2020

Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684861

1 reference

Dimensions Publication ID

22 September 2017

1003778799

0 references

Fatcat ID

release_3tir6xlyofa3dbihbnu245h5gy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3tir6xlyofa3dbihbnu245h5gy

24 November 2022

mapped directly with Wikidata item

1 reference